Skip to main content
Premium Trial:

Request an Annual Quote

Osler Diagnostics Raises $85M

NEW YORK — Osler Diagnostics said on Monday that it has raised $85 million in a Series C financing round.

Investors in the round included M&G Investments, Oxford Science Enterprises, Braavos Investment Advisers, and Lansdowne Partners.

The UK-based company said it will use the funding to continue development of Osler Origin, a portable, point-of-care diagnostic system.

"The Osler Origin platform has the potential to transform healthcare by enabling anyone, anywhere, to access, understand, and act on their healthcare information," Osler Cofounder and CEO Connor Campbell said in a statement. "This new investment allows us to advance the Osler Origin towards market."